Monitoring for Rare but Dangerous Side-Effects of Olanzapine Long- Acting Injection - A Completed Audit Cycle

Olanzapine long-acting injections are an effective way of delivering antipsychotic medication in maintenance treatment of schizophrenia. With every injection, there is a small but significant risk of post-injection syndrome, a rare but serious side effect characterized by potentially life-threatening sedation and/or delirium. Appropriate monitoring for post-injection syndrome is of paramount importance. This audit cycle aimed to establish appropriate standards for the monitoring of patients treated with olanzapine long-acting injections, and to assess, to what extent these standards were being implemented.